Methyl (R)-3-(6-bromochroman-2-yl)propanoate, 97%, 250mg

5-Chloro-2,4-difluorobenzoic acid, 98.0%, 100g

3-(1-AMINO-CYCLOPROPYL)-1-BOC-AZETIDINE, 95.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 2, 10 µl, 1701 RN, 1 piece

5-bromo-N,N-dimethyl-2-furamide, 95.0%, 1g

2-(tert-Butyl)-4,6-dichloropyrimidine, 97%, 250mg

5-Methyl-pyrimidine, 97.0%, 10g

Propionamide, 97.0%, 25g

(4-Chlorophenyl)(phenyl)methanamine, 95.0%, 250mg

3-Methoxy-5-nitrobenzoic acid, 95.0%, 100g

6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoic acid), 97%, 5g

(S)-3-(Boc-Amino)-4-phenylbutyric acid, 95.0%, 10g

1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one, 95.0%, 10g